Lisata Therapeutics Receives FDA Rare Pediatric Disease Designation for Lead Drug
An Uncommon Achievement: Lisata Therapeutics Secures FDA Rare Pediatric Disease Status for Pioneering Drug
Embarking on a quest to combat the insidious grip of disease, Lisata Therapeutics (NASDAQ:LSTA) … Read more







